Inventor · disambiguated record
Uday Khire
Also filed as: KHIRE UDAY · KHIRE UDAY R
20 granted patents·40 pending applications·518 citations·filing 1999–2015
96Inventor score
Top patents by PatentIndex Score
60 records- 0197US7235576B1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Jun 26, 2007·94 cites·47 claims
- 0296US7897623B2ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitorsBAYER HEALTHCARE LLC·Filed 2007·Granted Mar 1, 2011·35 cites·8 claims
- 0396US7625915B2Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER HEALTHCARE LLC·Filed 2007·Granted Dec 1, 2009·33 cites·1 claims
- 0496US7528255B2Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 5, 2009·35 cites·15 claims
- 0596US7351834B1ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Apr 1, 2008·64 cites·41 claims
- 0694US8841330B2Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2012·Granted Sep 23, 2014·12 cites·14 claims
- 0794US7329670B1Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER PHARMACEUTICALS CORP·Filed 1999·Granted Feb 12, 2008·76 cites·7 claims
- 0892US8153785B2Stabilizing ligands for regulation of protein functionKHIRE UDAY·Filed 2010·Granted Apr 10, 2012·28 cites·3 claims
- 0992US8124630B2ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2001·Granted Feb 28, 2012·27 cites·16 claims
- 1091US7371763B2Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER PHARMACEUTICALS CORP·Filed 2005·Granted May 13, 2008·17 cites·37 claims
- 1189US7648986B2Substituted thieno[3,2-D]pyrimidines as Rho kinase inhibitorsBAYER HEALTHCARE LLC·Filed 2007·Granted Jan 19, 2010·16 cites·8 claims
- 1286US7517880B2Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Apr 14, 2009·25 cites·21 claims
- 1386US6660752B22,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 9, 2003·24 cites·30 claims
- 1484US7928239B2Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER HEALTHCARE LLC·Filed 2001·Granted Apr 19, 2011·15 cites·18 claims
- 1579US8143393B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2006·Granted Mar 27, 2012·5 cites·11 claims
- 1678US8129379B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2009·Granted Mar 6, 2012·4 cites·2 claims
- 1772US9034861B2MEK inhibitors useful in the treatment of diseasesKHIRE UDAY R·Filed 2010·Granted May 19, 2015·4 cites·10 claims
- 1866US6919371B22,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Jul 19, 2005·2 cites·24 claims
- 1965US2008032979A1Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease InhibitorsRIEDL BERND·Filed 2007·Application pending·0 cites
- 2063US2008153823A1Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase InhibitorsRIEDL BERND·Filed 2007·Application pending·0 cites
- 2162US7645878B2Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereofBAYER HEALTHCARE LLC·Filed 2002·Granted Jan 12, 2010·2 cites·1 claims
- 2261US2008300281A1Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2008·Application pending·0 cites
- 2361US2009118268A1OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORSRIEDL BERND·Filed 2008·Application pending·0 cites
- 2459US2008194580A1Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl UreasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 2559US2007244120A1Inhibition of raf kinase using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 2658US2009093526A1Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasMILLER SCOTT·Filed 2007·Application pending·0 cites
- 2757US2014329866A1Omega-carboxyarl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2014·Application pending·0 cites
- 2857US2001027202A1Omega-carboxyaryl substituted disphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 2956US2010125139A1Process for preparing quinazoline rho-kinase inhibitors and intermediates thereofBANKSTON DONALD·Filed 2009·Application pending·0 cites
- 3055US2012046290A1Inhibition of p38 kinase activity using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 3153US2012129893A1Inhibition Of Raf Kinase Using Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2012·Application pending·0 cites
- 3253US2008108672A1Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase InhibitorsRIEDL BERND·Filed 2007·Application pending·0 cites
- 3353US2005215594A12,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 3452US2008269265A1Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl UreasMILLER SCOTT·Filed 2008·Application pending·0 cites
- 3552US2012270878A1Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasMILLER SCOTT·Filed 2012·Application pending·0 cites
- 3650US2001016659A1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 3750US2006142313A1Rho-kinase inhibitorsNAGARATHNAM DHANAPHALAN·Filed 2006·Application pending·0 cites
- 3850US2003105091A1Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitorsFiled 2002·Application pending·0 cites
- 3950US2001034447A1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 4049US2001011135A1Omega-carboxyaryl subsituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 4149US2004014755A1Rho-kinase inhibitorsFiled 2003·Application pending·0 cites
- 4249US2001011136A1omega-carboxyyaryl substituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 4348US2002137774A1Carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER AG·Filed 2001·Application pending·0 cites
- 4447US2003144278A1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER AG·Filed 2002·Application pending·0 cites
- 4547US2012149706A1Inhibition of p38 kinase activity using substituted heterocyclic ureasDUMAS JACQUES·Filed 2012·Application pending·0 cites
- 4646US8338594B2Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinaseMAGNUSON STEVEN·Filed 2006·Granted Dec 25, 2012·0 cites·14 claims
- 4746US2003125344A1Rho-kinase inhibitorsBAYER AG·Filed 2002·Application pending·0 cites
- 4846US2006142295A1Method of treating cancer with quinolone carboxylic acid derivativesDUMAS JACQUES·Filed 2004·Application pending·0 cites
- 4945US2012040986A1Omega carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2011·Application pending·0 cites
- 5043US2010216789A1Rho-kinase inhibitorsNAGARATHNAM DHANAPALAN·Filed 2010·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →